Dyadic International, Inc (NASDAQ:DYAI) VP Ronen Tchelet sold 10,000 shares of the stock in a transaction on Wednesday, July 10th. The shares were sold at an average price of $5.87, for a total transaction of $58,700.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Ronen Tchelet also recently made the following trade(s):
- On Monday, June 17th, Ronen Tchelet sold 20,000 shares of Dyadic International stock. The shares were sold at an average price of $6.11, for a total transaction of $122,200.00.
Shares of DYAI stock opened at $5.63 on Friday. Dyadic International, Inc has a 52-week low of $1.40 and a 52-week high of $7.30.
DYAI has been the subject of a number of recent research reports. TheStreet upgraded shares of Social Reality from a “d+” rating to a “c-” rating in a research note on Wednesday, April 17th. Noble Financial restated a “buy” rating and issued a $9.00 price objective on shares of Dyadic International in a research note on Monday, July 8th.
About Dyadic International
Dyadic International, Inc, a biotechnology platform company, engages in the development, production, and sale of enzymes and other proteins in the United States and the Netherlands. It utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial production of human and animal vaccines, monoclonal antibodies, bi-specific antibodies, fab antibody fragments, FC-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins.
Further Reading: What is a Swap?
Receive News & Ratings for Dyadic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International and related companies with MarketBeat.com's FREE daily email newsletter.